Sector revisions Dianthus Therapeutics, Inc.
Equities
DNTH
US2528281080
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.62 USD | -4.86% | -3.73% | +155.96% |
1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
9 | |||||||||
25 | |||||||||
29 | |||||||||
15 | |||||||||
18 | |||||||||
21 | |||||||||
17 | |||||||||
18 | |||||||||
- | - | - | 7 | ||||||
16 | |||||||||
25 | |||||||||
20 | |||||||||
19 | |||||||||
7 | |||||||||
- | - | - | - | ||||||
10 | |||||||||
21 | |||||||||
4 | |||||||||
13 | |||||||||
Average | 16 | ||||||||
Weighted average by Cap. | 22 |
- Stock Market
- Equities
- DNTH Stock
- Sector Dianthus Therapeutics, Inc.
- Sector revisions